News

Verywell Health on MSN11h
Not an 'Easy Way Out': How GLP-1 Users Navigate the Stigma of Weight Loss Drugs
Despite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 medications to support her weight loss goal. After six months on Wegovy ...
Endocrinology Advisor21h
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.
Gastroenterology Advisor11h
GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death
For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.